DK12780A - Fremgangsmaade til fremstilling af produkter omfattende muramylpeptider fikseret paa peptidpolymere - Google Patents
Fremgangsmaade til fremstilling af produkter omfattende muramylpeptider fikseret paa peptidpolymereInfo
- Publication number
- DK12780A DK12780A DK12780A DK12780A DK12780A DK 12780 A DK12780 A DK 12780A DK 12780 A DK12780 A DK 12780A DK 12780 A DK12780 A DK 12780A DK 12780 A DK12780 A DK 12780A
- Authority
- DK
- Denmark
- Prior art keywords
- peptide
- residues
- acid
- procedure
- products including
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 4
- 229920000642 polymer Polymers 0.000 title abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 125000000539 amino acid group Chemical group 0.000 abstract 3
- OGNSCSPNOLGXSM-UHFFFAOYSA-N 2,4-diaminobutyric acid Chemical compound NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 abstract 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 abstract 2
- 239000004472 Lysine Substances 0.000 abstract 2
- 125000000266 alpha-aminoacyl group Chemical group 0.000 abstract 2
- QWCKQJZIFLGMSD-UHFFFAOYSA-N 2-Aminobutanoic acid Natural products CCC(N)C(O)=O QWCKQJZIFLGMSD-UHFFFAOYSA-N 0.000 abstract 1
- QWCKQJZIFLGMSD-GSVOUGTGSA-N D-alpha-aminobutyric acid Chemical compound CC[C@@H](N)C(O)=O QWCKQJZIFLGMSD-GSVOUGTGSA-N 0.000 abstract 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 abstract 1
- 239000004471 Glycine Substances 0.000 abstract 1
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 abstract 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 abstract 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 abstract 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 abstract 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 abstract 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 abstract 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 abstract 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 abstract 1
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 abstract 1
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 abstract 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 abstract 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 abstract 1
- 235000004279 alanine Nutrition 0.000 abstract 1
- 230000002924 anti-infective effect Effects 0.000 abstract 1
- 235000013922 glutamic acid Nutrition 0.000 abstract 1
- 239000004220 glutamic acid Substances 0.000 abstract 1
- 239000012678 infectious agent Substances 0.000 abstract 1
- 125000001446 muramyl group Chemical group N[C@@H](C=O)[C@@H](O[C@@H](C(=O)*)C)[C@H](O)[C@H](O)CO 0.000 abstract 1
- 229960003104 ornithine Drugs 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 239000004474 valine Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
- C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
- C07K9/005—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure containing within the molecule the substructure with m, n > 0 and m+n > 0, A, B, D, E being heteroatoms; X being a bond or a chain, e.g. muramylpeptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/19—Antibiotic
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/29—Polyamino acid or polypeptide with an uninterrupted series of peptide repeating units
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Crystallography & Structural Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Polyamides (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7900819A FR2446292A1 (fr) | 1979-01-12 | 1979-01-12 | Muramyl-peptides fixes sur polymeres peptidiques et medicaments les contenant |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK12780A true DK12780A (da) | 1980-07-13 |
Family
ID=9220713
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK12780A DK12780A (da) | 1979-01-12 | 1980-01-11 | Fremgangsmaade til fremstilling af produkter omfattende muramylpeptider fikseret paa peptidpolymere |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US4401659A (da) |
| EP (1) | EP0013651B1 (da) |
| JP (1) | JPS5594934A (da) |
| AT (1) | ATE3773T1 (da) |
| DE (1) | DE3063712D1 (da) |
| DK (1) | DK12780A (da) |
| ES (1) | ES8107247A1 (da) |
| FR (1) | FR2446292A1 (da) |
| IE (1) | IE49045B1 (da) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4522811A (en) * | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| FR2533827A1 (fr) * | 1982-09-30 | 1984-04-06 | Anvar | Composition possedant des proprietes immunoregulatrices, notamment d'adjuvants immunologiques non specifiques, a base de muramylpeptide et d'un derive d'aluminium |
| FR2546756B1 (fr) * | 1983-06-03 | 1985-11-29 | Centre Nat Rech Scient | Nouveaux derives immunostimulants, leur preparation et leur application comme medicament |
| FR2583049B1 (fr) * | 1985-06-10 | 1988-08-05 | Anvar | Produits resultant de la conjugaison d'un support macromoleculaire, d'un haptene et d'un muramyl-peptide par l'intermediaire d'un groupement substituant la partie saccharidique du muramyl-peptide et compositions selectivement immunogenes contenant ces produits |
| DK585886A (da) * | 1985-12-24 | 1987-06-25 | Takeda Chemical Industries Ltd | Immunstimulerende middel og anvendelse deraf |
| US5416070A (en) * | 1988-07-08 | 1995-05-16 | Immunotherapeutics, Inc. | Composition for macrophage activation |
| US4950645A (en) * | 1988-07-08 | 1990-08-21 | Immunotherapeutics, Inc. | Composition for macrophage activation |
| IT1237903B (it) * | 1989-12-14 | 1993-06-18 | Medidom Lab | Derivati semisintetici ad attivita' immunomodulante atti alla somminitrazione parenterale ed orale |
| FR2692149B1 (fr) * | 1992-06-12 | 1995-06-09 | Vacsyn France Sa | Composition adjuvante de l'immunite humorale et a mediation cellulaire n'induisant pas de reponse vis-a-vis de determinants auto-antigeniques. |
| US6281191B1 (en) | 1997-12-29 | 2001-08-28 | Vladimir I. Slesarev | Compositions and methods for treating hepatitis-C |
| US7625695B2 (en) * | 2006-08-24 | 2009-12-01 | Samsung Electronics Co., Ltd. | Polymers for anti-reflective coatings, anti-reflective coating compositions and methods of forming a pattern using the same |
| US10792301B2 (en) * | 2015-02-13 | 2020-10-06 | The University Of Toledo | Therapeutic polysaccharide midi-GAGR and related materials and methods |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1155134B (de) * | 1958-06-07 | 1963-10-03 | Hoechst Ag | Verfahren zur Herstellung von Blutplasmaersatzmitteln aus Kollagenabbauprodukten |
| CH538003A (fr) * | 1968-03-29 | 1973-01-31 | Anvar | Procédé pour l'obtention d'articles textiles porteurs d'enzymes |
| US4186194A (en) * | 1973-10-23 | 1980-01-29 | Agence Nationale De Valorisation De La Recherche (Anvar) | Water soluble agents effective as immunological adjuvants for stimulating, in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents |
| DE2450955C2 (de) * | 1974-10-26 | 1976-09-29 | Ofenbaugesellschaft Berg & Co | Verfahren und Vorrichtung zum Patentleren von zu Bunden gehaspeltem Stahldraht |
| FR2321896A1 (fr) * | 1975-08-29 | 1977-03-25 | Anvar | Agents adjuvants immunologiques actifs en solution aqueuse |
| CH613709A5 (en) * | 1975-12-10 | 1979-10-15 | Ciba Geigy Ag | Process for the preparation of glucosamine derivatives |
| US4082735A (en) * | 1976-04-26 | 1978-04-04 | Syntex (U.S.A.) Inc. | Novel immunological adjuvant compounds and methods of preparation thereof |
| US4082736A (en) * | 1976-04-26 | 1978-04-04 | Syntex (U.S.A.) Inc. | Novel immunological adjuvant compounds and methods of preparation thereof |
| FR2358159A1 (fr) * | 1976-07-16 | 1978-02-10 | Anvar | Le diamide de l'acide 2-(2-acetamido-2-deoxy-3 - o-d-glucopyranosyl) - d-propionyl-l-alanyl-d-glutamique et medicaments le contenant |
| CA1138436A (en) * | 1978-02-24 | 1982-12-28 | Gerhard Baschang | Process for the manufacture of novel antigens |
-
1979
- 1979-01-12 FR FR7900819A patent/FR2446292A1/fr active Granted
-
1980
- 1980-01-11 IE IE53/80A patent/IE49045B1/en unknown
- 1980-01-11 AT AT80400041T patent/ATE3773T1/de not_active IP Right Cessation
- 1980-01-11 DK DK12780A patent/DK12780A/da not_active Application Discontinuation
- 1980-01-11 DE DE8080400041T patent/DE3063712D1/de not_active Expired
- 1980-01-11 JP JP198080A patent/JPS5594934A/ja active Pending
- 1980-01-11 EP EP80400041A patent/EP0013651B1/fr not_active Expired
- 1980-01-12 ES ES487926A patent/ES8107247A1/es not_active Expired
- 1980-01-14 US US06/111,701 patent/US4401659A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5594934A (en) | 1980-07-18 |
| ES487926A0 (es) | 1980-12-16 |
| IE800053L (en) | 1980-07-12 |
| DE3063712D1 (en) | 1983-07-21 |
| FR2446292B1 (da) | 1983-01-07 |
| US4401659A (en) | 1983-08-30 |
| IE49045B1 (en) | 1985-07-10 |
| EP0013651B1 (fr) | 1983-06-15 |
| FR2446292A1 (fr) | 1980-08-08 |
| ES8107247A1 (es) | 1980-12-16 |
| ATE3773T1 (de) | 1983-06-15 |
| EP0013651A1 (fr) | 1980-07-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK12780A (da) | Fremgangsmaade til fremstilling af produkter omfattende muramylpeptider fikseret paa peptidpolymere | |
| ATE108662T1 (de) | Antimikrobielle peptide, zusammensetzungen, die diese enthalten, und verwendungen daraus. | |
| CA2153789A1 (en) | Biologically active tgf-.beta.1 and tgf-.beta.2 peptides | |
| DE69713112D1 (de) | Zusammensetzungen und methoden zur behandlung von infektionen unter verwendung von indolicidin-analogen | |
| PE27599A1 (es) | Peptidos y compuestos que se enlazan a un receptor | |
| ATE168719T1 (de) | Osteogene peptide | |
| DE69723812D1 (de) | Aminosäurezusammensetzungen | |
| WO1995003327A3 (en) | Peptides for neutralizing the toxicity of lipid a | |
| DE68927379D1 (de) | Plättchen blockierende peptide | |
| ATE118686T1 (de) | Biologisch wirksame polymere arzneistoffderivate. | |
| ES2038675T3 (es) | Un procedimiento para preparar compuestos peptidicos. | |
| GR3031889T3 (en) | Lipopeptide inducing T-cytotoxic lymphocytes and their use as vaccines. | |
| KR890013061A (ko) | 폴리펩티드 유도체 | |
| ATE30919T1 (de) | Magensekretion hemmende peptidderivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel. | |
| DE3751398D1 (de) | Substrat-Peptide. | |
| DE69117965D1 (de) | Peptide, welche hiv-retroviren-hemmende antikörper induzieren, sowie gegen diese peptide gerichtete antikörper | |
| NZ335136A (en) | Isolated peptides which complex with hla-cw*16 molecules, and uses thereof | |
| DE59108261D1 (de) | Peptide des HIV-gag Proteins, ihre Herstellung und Verwendung | |
| Harada et al. | Characterization of functional groups of acidic thermal polymers of α-amino acids | |
| RU2001113277A (ru) | Регуляторные/развернутые пептиды эзрина | |
| ES2071038T3 (es) | Peptidos asociados al hiv. | |
| DE69613086D1 (de) | Antigenen Peptide mit Glycinsubstitution | |
| RU2005106244A (ru) | Связывающие молекулы |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AHB | Application shelved due to non-payment |